Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Pharmacology

• Publication date

  2000-10-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-2999(00)00687-7PMID 11040343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human.

  2000cited by this paper
• Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

  1999cited by this paper
• The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons.

  1999cited by this paper
• Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor

  1999cited by this paper
• Discovery and characterization of endogenous cannabinoids.

  1999cited by this paper
• Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.

  1999cited by this paper
• Anandamide and WIN 55212‐2 inhibit cyclic AMP formation through G‐protein‐coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes

  1999cited by this paper
• Vanilloid (Capsaicin) receptors and mechanisms.

  1999cited by this paper
• The endothelial component of cannabinoid‐induced relaxation in rabbit mesenteric artery depends on gap junctional communication

  1999cited by this paper
• Pharmacology of cannabinoid receptor ligands.

  1999cited by this paper
• Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.

  1999cited by this paper
• Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

  1999cited by this paper
• Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

  1999cited by this paper
• Mesenteric vasodilation mediated by endothelial anandamide receptors.

  1999cited by this paper
• The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery

  1998cited by this paper
• Endocannabinoids.

  1998cited by this paper
• The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

  1998cited by this paper
• Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.

  1998cited by this paper
• Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.

  1998cited by this paper
• ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance

  1998cited by this paper
• Cannabinoid Receptor Agonist Efficacy for Stimulating [35S]GTPγS Binding to Rat Cerebellar Membranes Correlates with Agonist-induced Decreases in GDP Affinity*

  1998cited by this paper
• Evaluation of Cannabinoid Receptor Agonists and Antagonists Using the Guanosine-5 9-O-( 3-[ 35 S ] thio )-triphosphate Binding Assay in Rat Cerebellar Membranes 1

  1998cited by this paper
• Cannabinoid receptors and their endogenous agonists.

  1998cited by this paper
• Interactions between synthetic vanilloids and the endogenous cannabinoid system

  1998cited by this paper
• Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.

  1998cited by this paper
• 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

  1998cited by this paper
• Dual Effects of Anandamide on NMDA Receptor‐Mediated Responses and Neurotransmission

  1998cited by this paper
• Existence of capsaicin‐sensitive glutamatergic terminals in rat hypothalamus

  1998cited by this paper
• The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity.

  1997cited by this paper
• Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes.

  1997cited by this paper
• The capsaicin receptor: a heat-activated ion channel in the pain pathway

  1997cited by this paper
• Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells.

  1997cited by this paper
• Anandamide, an endogenous cannabinoid, inhibits Shaker-related voltage-gated K+ channels.

  1996cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

  1995cited by this paper
• Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons.

  1995cited by this paper
• The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

  1994cited by this paper
• Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

  1993cited by this paper
• Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.

  1993cited by this paper
• Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor.

  1993cited by this paper
• Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding.

  1993cited by this paper
• Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

  1993cited by this paper
• Identification of alpha-1-acid glycoprotein (orosomucoid) as a major vanilloid binding protein in serum.

  1992cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.

  1992cited by this paper
• Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.

  1992cited by this paper
• Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.

  1991cited by this paper
• The effects of a series of capsaicin analogues on nociception and body temperature in the rat.

  1984cited by this paper
• Dihydrocapsaicin-induced hypothermia and substance P depletion.

  1982cited by this paper
• Intrathecal morphine in mice: a new technique.

  1980cited by this paper

• Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission.

  2024cites this paper
• A type II cannabis extract and a 1:1 blend of Δ(9)-tetrahydrocannabinol and cannabidiol display distinct antinociceptive profiles and engage different endocannabinoid targets when administered into the subarachnoid space

  2023cites this paper
• Comparison of the Anticancer Effects of Arvanil and Olvanil When Combined with Cisplatin and Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis

  2022cites this paper
• Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice

  2020cites this paper
• acid lipid sensing and intake in mice.

  2020cites this paper
• Affinin and hexahydroaffinin: Chemistry and toxicological profile

  2020cites this paper
• Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems—A Novel Treatment Option for Chronic Pain Management

  2016cites this paper
• New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds

  2015cites this paper
• Sensory nerves contribute to cutaneous vasodilator response to cathodal stimulation in healthy rats.

  2015cites this paper
• Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system.

  2015cites this paper
• Fatty Acid Amide Hydrolase-Dependent Generation of Antinociceptive Drug Metabolites Acting on TRPV1 in the Brain

  2013cites this paper
• Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.

  2012cites this paper
• Regulation of GPR119 receptor activity with endocannabinoid-like lipids.

  2012cites this paper
• N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity.

  2011cites this paper
• Behavioral / Systems / Cognitive Thermoregulatory Phenotype of the Trpv 1 Knockout Mouse : Thermoeffector Dysbalance with Hyperkinesis

  2011cites this paper
• Discriminative stimulus properties of 3-substituent rimonabant analogs

  2011cites this paper
• Thermoregulatory Phenotype of the Trpv1 Knockout Mouse: Thermoeffector Dysbalance with Hyperkinesis

  2011cites this paper
• Neurochemistry of Endogenous Antinociception

  2011cites this paper
• The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.

  2011cites this paper
• The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors

  2011cites this paper
• Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors

  2011influential citation
• Midcervical vagotomy precludes respiratory response to novel anti-inflammatory and anti-tumour drug arvanil in rats.

  2010cites this paper
• Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.

  2009cites this paper
• 5 Anandamide and Other Acylethanolamides

  2009cites this paper
• Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1.

  2008cites this paper
• TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications.

  2008cites this paper
• The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level

  2008influential citation
• Role of VR1 and CB1 receptors in modelling of cardio-respiratory response to arvanil, an endocannabinoid and vanilloid hybrid, in rats.

  2008cites this paper
• An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain.

  2008cites this paper
• 5-HT reuptake and 5-HT2 receptors modulate capsaicin-evoked hypothermia in rats.

  2008cites this paper
• The Endocannabinoid System in the Physiology and Pathology of the Basal Ganglia

  2008cites this paper
• Cannabinoids and the brain

  2008cites this paper
• Arvanil, anandamide and N‐arachidonoyl‐dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret

  2007cites this paper
• A COMPARISION OF DELTA-9-TETRAHYDROCANNABINOL DEPENDENCE IN C57Bl/6j MICE AND FATTY ACID AMIDE HYDROLASE KNOCK OUT MICE

  2007cites this paper
• Cannabinoids and Multiple Sclerosis

  2007cites this paper
• Capsaicin and nitric oxide synthase inhibitor interact to evoke a hypothermic synergy.

  2006cites this paper
• Iodinated N-Acylvanillamines: Potential “Multiple-Target” Anti-Inflammatory Agents Acting via the Inhibition of T-Cell Activation and Antagonism at Vanilloid TRPV1 Channels

  2006cites this paper
• Cannabinoids and prefrontal cortical function: insights from preclinical studies.

  2006cites this paper
• The endocannabinoid and endovanilloid systems and their interactions in neuropathic pain

  2006cites this paper
• First “hybrid” ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non‐polyunsaturated fatty acid‐derived CB2‐selective ligands

  2006cites this paper
• Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.

  2006cites this paper
• Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum: A Combined Immunochemical and Pharmacological Analysis

  2005cites this paper
• Molecular Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum : A Combined Immunochemical and Pharmacological Analysis

  2005cites this paper
• Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors

  2005cites this paper
• Vascular effects of anandamide and N‐acylvanillylamines in the human forearm and skin microcirculation

  2005cites this paper
• Focus on the three key enzymes hydrolysing endocannabinoids as new drug targets.

  2005cites this paper
• Capsaicin exhibits neuroprotective effects in a model of transient global cerebral ischemia in Mongolian gerbils

  2005cites this paper
• Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease.

  2005cites this paper
• Effects of cannabinoids on hypothalamic and reproductive function.

  2005cites this paper
• Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors.

  2005cites this paper
• The endocannabinoid system and its therapeutic exploitation

  2004cites this paper
• A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats.

  2004cites this paper
• Effects of the vanilloid agonist olvanil and antagonist capsazepine on rat behaviors.

  2004cites this paper
• A new strategy to block tumor growth by inhibiting endocannabinoid inactivation

  2004cites this paper
• Cannabinoid pharmacological properties common to other centrally acting drugs.

  2003cites this paper
• Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists

  2003cites this paper
• The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase‐8‐dependent pathway

  2003cites this paper
• Neuromodulatory actions neuromodulatory actions of endocannabinoids in pain and sedation.

  2003cites this paper
• Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils.

  2003cites this paper
• Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response

  2003cites this paper
• Effect of arvanil (N-arachidonoyl-vanillyl-amine), a nonpungent anandamide-capsaicin hybrid, on ion currents in NG108-15 neuronal cells.

  2003cites this paper
• Neuroprotection by the Endogenous Cannabinoid Anandamide and Arvanil against In Vivo Excitotoxicity in the Rat: Role of Vanilloid Receptors and Lipoxygenases

  2003cites this paper
• FACULTE MIXTE DE MEDECINE ET DE PHARMACIE DE ROUEN

  2002cites this paper
• Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function.

  2002cites this paper
• After a decade of intravesical vanilloid therapy: still more questions than answers.

  2002cites this paper
• Cannabinoids and multiple sclerosis.

  2002cites this paper
• Effect of piperine, the active ingredient of black pepper, on intestinal secretion in mice.

  2002cites this paper
• Recent advances in the cannabinoids

  2002cites this paper
• Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.

  2002cites this paper
• Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors.

  2002cites this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cites this paper
• A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.

  2002influential citation
• The role of endocannabinoids in the hypothalamic regulation of visceral function.

  2002cites this paper
• Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.

  2002cites this paper
• Anandamide receptors.

  2002cites this paper
• Cannabinoid receptors and their ligands.

  2002cites this paper
• Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.

  2001cites this paper
• Modulateurs de l'absorption d'endocannabinoide et des recepteurs de vallinoide

  2001cites this paper
• Vanilloid Receptor Ligands

  2001cites this paper
• Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

  2001cites this paper
• Vanilloïdes, cannabinoïdes et nociception: aspects anatomiques

  2001cites this paper
• Endocannabinoids Part II: pathological CNS conditions involving the endocannabinoid system and their possible treatment with endocannabinoid-based drugs

  2001cites this paper
• Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.

  2001cites this paper
• The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism*

  2001cites this paper
• Endocannabinoids Part I: Molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors

  2001cites this paper
• Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity

  2000cites this paper
• New perspectives on enigmatic vanilloid receptors.

  2000cites this paper